About Michael Ullmann
Michael Ullmann is a director at Cytogel Pharma.
Michael Ullmann first appears on SEC filings in 2024.
Experience
This experience comes from Michael Ullmann's profile and from SEC filings. For roles taken from filings, the years are when the filings name Michael Ullmann in the role, so the role may have started earlier or lasted longer.
Cytogel Pharma, LLC Current
Director
2024 – Present · Darien, CT
Develops investigational medicines for people with moderate to severe pain.
CU
Columbia University Current
Adjunct Faculty Member
2024 – Present
MT
Massachusetts Institute of Technology Current
MIT Committee Member
2023 – Present
PF
Princeton Area Community Foundation Current
Vice Chair, Board of Trustees
2023 – Present
NP
Naples Zoo (non-profit) Current
Board Member
2023 – Present
AM
Americares Current
Vice Chair, Board of Directors
2019 – Present
JJ
Johnson & Johnson
Executive Vice President, General Counsel & Executive Committee Member
1989 – 2023
Key Colleagues at Startups
The people Michael Ullmann works with at each company, as listed on that company's latest Form D.
Cytogel Pharma, LLC · Form D/A, Mar 26, 2026
C. Maglaris
CEO & Chair of Board of Managers
JL
Jerry Leamon
Director
Theodore Maione
Chief Scientific Officer
SC
Steven Chrust
Outside and director
EL
Eric Lang
Director
FT
Frederick Telling
Outside and director
CK
Cassandra Klimp
Non-executive Director